Concepedia

Liuqing Xu

LX

Statistics

Publications

10

Citations

628

H-Index

10

Active since

2015

Affiliations

Shanghai East Hospital(Current)

Rhode Island Hospital

Brown University

Tongji University

The First Affiliated Hospital, Sun Yat-sen University

Liuqing Xu is an author at Shanghai East Hospital specializing in pharmacology, signal transduction, and renal pharmacology.

Publications per year

2015–2019

10

Publications

10

EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy

Na Liu, Li Wang, Tao Yang et al. · Journal of the American Society of Nephrology · 2015 · 126 citations · Full text

Medicine, Nephrology, Pharmacology +17

Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury

Yingfeng Shi, Liuqing Xu, Jinhua Tang et al. · American Journal of Physiology-Renal Physiology · 2017 · 81 citations

Medicine, Biochemistry, Pharmacology +17

3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression

Jun Ni, Xiying Hou, Xueqiao Wang et al. · Cell Death and Disease · 2019 · 73 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease

Feng Liu, Li Wang, Hualin Qi et al. · Clinical Science · 2017 · 69 citations

Medicine, Nephrology, Pharmacology +17

Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury

Jinhua Tang, Yingfeng Shi, Na Liu et al. · Clinical Science · 2018 · 66 citations

Medicine, Oncology, Pharmacology +15

1–5 of 10